Advertisements


Takeda CEO prescribes surgical R&D cuts after $62 billion Shire deal

LONDON (Reuters) - For Christophe Weber, the boss of Japan's Takeda Pharmaceutical , securing a $62 billion deal last week to buy drugmaker Shire at the fifth time of asking was the easy bit......»»

Category: topSource: reutersMay 17th, 2018

Takeda clears key hurdle as investors back $59 billion Shire deal

Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire , creating a global powerhouse that has a stronger drugs pipeline but is also saddled with massive debt......»»

Category: topSource: reutersDec 5th, 2018

Takeda's Shareholders Agree to $58 Billion Shire Deal Despite Debt Fears - Fortune

FortuneTakeda's Sharehold.....»»

Category: topSource: googlenewsDec 5th, 2018

Takeda investors back $59 billion Shire deal, but wary of debt load

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt......»»

Category: topSource: reutersDec 5th, 2018

Takeda’s Shareholders Agree to $58 Billion Shire Deal Despite Debt Fears

Takeda will issue $35 billion in new stock. The long-running saga that is Takeda’s proposed takeover of Adderall maker Shire is about to enter a new chapter, with the Japanese firm’s shareholders approving the deal. On Wednesday.....»»

Category: europeSource: fortuneDec 5th, 2018

Shire-Takeda deal gets conditional EU approval, heads to shareholders

European Union antitrust regulators have conditionally approved Takeda Pharmaceutical Co. Ltd.'s $62 billion bid to acquire Shire plc, a deal that will likely create the largest life sciences employer in Massachusetts. The European Commission sai.....»»

Category: topSource: bizjournalsNov 20th, 2018

Investor advisory firms back Takeda"s $62 billion deal for Shire

Two shareholder advisory firms have backed Takeda Pharmaceutical's $62 billion takeover offer for drugmaker Shire , dealing a blow to a group of investors who hope to block the deal......»»

Category: topSource: reutersNov 20th, 2018

Takeda"s Shire takeover to bring $963 million fee bonanza

Banks, law firms and other advisers stand to earn up to $963 million in fees from Takeda Pharmaceutical's $62 billion takeover of drugmaker Shire , according to documents for the deal published on Monday......»»

Category: topSource: reutersNov 12th, 2018

Takeda sets vote date, aims to close $62 billion Shire deal Jan. 8

Japan's Takeda Pharmaceutical will hold an investor vote on its $62 billion acquisition of Shire next month and aims to close the deal on Jan. 8, signaling its confidence in securing the required support......»»

Category: topSource: reutersNov 12th, 2018

Exclusive: Takeda to win EU approval for $62 billion Shire deal - sources

Japanese drugmaker Takeda Pharmaceutical is set to win conditional EU antitrust approval for its $62-billion bid for London's Shire, the biggest ever overseas acquisition by a Japanese company, two people familiar with the matter said on Friday......»»

Category: topSource: reutersNov 9th, 2018

Takeda CEO confident of investor backing for $62 billion Shire deal

The boss of Japan's Takeda Pharmaceutical said on Monday he was confident of securing investor backing for its $62 billion acquisition of London-listed Shire , despite some shareholders' fears about the resulting debt burden......»»

Category: topSource: reutersNov 5th, 2018

Takeda gets Japanese approval for Shire takeover, awaits EU nod

On Thursday, Takeda Pharmaceutical Co. Ltd. said that Japan's Fair Trade Commission has approved its $62 billion bid to acquire the second-largest biotech employer in Massachusetts, Shire Pharmaceuticals plc. According to Reuters, the deal has alre.....»»

Category: topSource: bizjournalsOct 18th, 2018

Takeda gets Japanese approval for $62 billion Shire purchase

Takeda Pharmaceutical Co Ltd said on Thursday Japan's Fair Trade Commission had approved its $62 billion acquisition of Shire Plc , bringing the Japanese firm closer to sealing a deal that will make it a global top 10 drugmaker......»»

Category: topSource: reutersOct 18th, 2018

Takeda weighs sale of Shire"s eye care business to cut debt: Bloomberg

Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks to cut the debt raised to fund the deal, Bloomberg reported on Thursday......»»

Category: topSource: reutersSep 13th, 2018

Takeda to close Illinois office, move employees to Mass.

Takeda Pharmaceuticals has announced plans to close its U.S. sales office in Deerfield, Illinois, and relocate employees to the Boston area. The announcement comes on the heels of Japan-based Takeda's $62 billion deal to acquire Shire plc, one of the la.....»»

Category: topSource: bizjournalsSep 11th, 2018

Takeda gets key U.S. regulatory approval to buy Shire

Japan's Takeda Pharmaceutical Co Ltd said on Tuesday it received a key U.S. regulatory approval for its $62 billion deal to buy London-listed Shire Plc......»»

Category: topSource: reutersJul 10th, 2018

Takeda shareholder group aims to block $62B Shire deal

A group of Takeda Pharmaceutical shareholders is trying to build support to block the $62 billion acquisition of London-listed Shire at an extraordinary general meeting, a leading member of the group told Reuters on Monday......»»

Category: topSource: moneycentralJun 11th, 2018

Takeda shareholder group aims to block $62 billion Shire deal

TOKYO (Reuters) - A group of Takeda Pharmaceutical Co Ltd shareholders is trying to build support to block the $62 billion acquisition of London-listed Shire Plc at an extraordinary general meeting, a leading member of the group told Reuters on Monday......»»

Category: topSource: reutersJun 11th, 2018

Takeda shareholders group say working to block $62 billion Shire deal

TOKYO (Reuters) - A group of Takeda Pharmaceutical Co Ltd shareholders is building support to block the $62 billion acquisition of London-listed Shire Plc at an extraordinary general meeting, a leading member of the group told Reuters on Monday......»»

Category: topSource: reutersJun 11th, 2018

Takeda global ambitions grow after Shire takeover

Takeda Pharmaceutical hopes that their $62 billion deal to purchase Shire will make them a global bio-pharmaceutical leader. But as Silvia Antonioli reports, it comes with a heavy debt burden......»»

Category: videoSource: reutersMay 9th, 2018

Takeda to takeover bigger rival Shire in $62bln deal

Takeda Pharmaceutical agrees to buy London-listed Shire for 45.3 billion pounds ($61.5.....»»

Category: topSource: usatodayMay 8th, 2018